LS Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,471
Closed -$65K 1143
2020
Q2
$65K Hold
2,471
﹤0.01% 1105
2020
Q1
$62K Hold
2,471
﹤0.01% 1055
2019
Q4
$89K Buy
2,471
+1,884
+321% +$65K ﹤0.01% 1145
2019
Q3
$20K Hold
587
﹤0.01% 1534
2019
Q2
$16K Hold
587
﹤0.01% 1581
2019
Q1
$18K Hold
587
﹤0.01% 1536
2018
Q4
$14K Sell
587
-3,027
-84% -$82.7K ﹤0.01% 1559
2018
Q3
$140K Sell
3,614
-872
-19% -$31.4K 0.01% 1006
2018
Q2
$150K Buy
4,486
+121
+3% +$4.3K 0.01% 1000
2018
Q1
$158K Sell
4,365
-59
-1% -$2.04K 0.01% 961
2017
Q4
$141K Sell
4,424
-86
-2% -$2.95K 0.01% 1046
2017
Q3
$169K Buy
4,510
+1,330
+42% +$45.3K 0.01% 1000
2017
Q2
$99K Buy
+3,180
New +$91.8K 0.01% 1137

Other funds holding LMAT

LS Investment Advisors's LMAT Position: Q3 2020 in Review

LS Investment Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2020, closing a stake of 2,471 shares — an estimated $65K sold.

LS Investment Advisors first reported a position in LMAT in Q2 2017 and held it in 13 quarters. The position peaked at $169K in Q3 2017. 141 funds tracked by Wall St. Rank hold LMAT as of Q3 2020.

  • LS Investment Advisors reported no remaining LeMaitre Vascular position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 2,471 LeMaitre Vascular shares in Q3 2020, an estimated $65K.
  • LS Investment Advisors first reported a position in LeMaitre Vascular in Q2 2017 and held it in 13 quarters.
  • LS Investment Advisors's LeMaitre Vascular position peaked at $169K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.